2021年发表SCI论文情况汇总

时间: 2022-04-13 作者: 曾园园浏览次数: 10

序号	年度	文章题目	通讯作者	第一作者	发表杂志	卷期号	影响因子
1	2021	Moesin Is a Novel Biomarker of Endothelial Injury in Sepsis	黄建安	陈义坤，王佳佳	J Immunol Res	2021 Feb 13;2021:6695679. doi: 10.1155/2021/6695679. eCollection 2021.	4.818
2	2021	KPNB1-mediated nuclear translocation of PD-L1 promotes non-**all cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway	刘泽毅，黄建安	杜雯雯，朱健洁，曾园园	Cell Death Differ	2021 Apr;28(4):1284-1300. doi: 10.1038/s41418-020-00651-5. Epub 2020 Nov 2.	15.828
3	2021	CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-**all cell lung cancer	黄建安，刘泽毅	朱健洁，蔡婷婷，周洁琦	J Exp Clin Cancer Res	2021 Jun 9;40(1):192. doi: 10.1186/s13046-021-01998-4.	11.161
4	2021	HIF-1α promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment	黄建安，刘泽毅	伏冉，杜雯雯，丁宗励	Cell Death Dis	2021 Apr 13;12(4):394. doi: 10.1038/s41419-021-03682-z.	8.469
5	2021	Advanced NSCLC Patients With EGFR T790M Harboring TP53 R273C or KRAS G12V Cannot Benefit From Osimertinib Based on a Clinical Multicentre Study by Tissue and Liquid Biopsy	黄建安，刘泽毅	符宇龙，王安祺	Front Oncol	2021 Feb 24;11:621992. doi: 10.3389/fonc.2021.621992. eCollection 2021.	6.244
6	2021	Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma	黄建安，刘泽毅	李岳，沈若怡	Front Cell Dev Biol	2021 Mar 18;9:648806. doi: 10.3389/fcell.2021.648806. eCollection 2021.	6.684
7	2021	ALCAP2 inhibits lung adenocarcinoma cell proliferation, migration and invasion via the ubiquitination of β-catenin by upregulating the E3 ligase NEDD4L	黄建安，刘泽毅	张伟杰，张若琛	Cell Death Dis	2021 Jul 31;12(8):755. doi: 10.1038/s41419-021-04043-6.	8.469
8	2021	The regulation of CPNE1 ubiquitination by the NEDD4L is involved in the pathogenesis of non-**all cell lung cancer	黄建安，刘泽毅	张若琛，曾园园，张伟杰	Cell Death Discov	2021 Nov 6;7(1):336. doi: 10.1038/s41420-021-00736-1.	5.241